MeVis Medical Solutions AG provided earnings guidance for the fiscal year ending September 30, 2019. For the year, the company expects slight decline in revenues to EUR 16.0 million to EUR 16.5 million. The expected revenue decline in the Digital Mammography segment will only be partially offset by the forecasted revenue growth in the Development Services and Other Operating Activities segments. Earnings before financial result and taxes (EBIT) are expected to decline significantly to between EUR 1.5 million and EUR 2.0 million. This includes an expected impairment of goodwill for the Hologic business of EUR 4.5 million.